The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.

 
Web www.patentalert.com

< Ligand activated transcriptional regulator proteins

> Polynucleotides that hybridize to DP-75 and their use

~ 00408